{"name":"MPM Capital","permalink":"mpm-capital","crunchbase_url":"http://www.crunchbase.com/financial-organization/mpm-capital","homepage_url":"http://www.mpmcapital.com/","blog_url":"","blog_feed_url":"","twitter_username":"","phone_number":"617-425-9200","description":"Healthcare Venture Capital","email_address":"","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"tag_list":null,"alias_list":"","created_at":"Wed May 20 20:06:41 UTC 2009","updated_at":"Tue May 26 20:22:38 UTC 2009","overview":"<p>Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can &#8220;drop in&#8221; expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.</p>","image":{"available_sizes":[[[150,142],"assets/images/resized/0004/5561/45561v1-max-150x150.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-250x250.png"],[[180,171],"assets/images/resized/0004/5561/45561v1-max-450x450.png"]],"attribution":null},"offices":[{"description":"Boston Office","address1":"The John Hancock Tower","address2":"200 Clarendon Street 54th Floor","zip_code":"02116","city":"Boston","state_code":"MA","country_code":"USA","latitude":null,"longitude":null},{"description":"San Francisco Office","address1":"601 Gateway Boulevard ","address2":"Suite 350","zip_code":"94080","city":"San Francisco","state_code":"CA","country_code":"USA","latitude":37.658713,"longitude":-122.399382}],"relationships":[],"investments":[{"funding_round":{"round_code":"c","source_url":"http://www.reuters.com/article/pressRelease/idUS134328+20-Jan-2009+PRN20090120","source_description":"TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing","raised_amount":37000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":1,"funded_day":null,"company":{"name":"Taigen","permalink":"taigen","image":{"available_sizes":[[[150,81],"assets/images/resized/0004/3263/43263v1-max-150x150.png"],[[174,94],"assets/images/resized/0004/3263/43263v1-max-250x250.png"],[[174,94],"assets/images/resized/0004/3263/43263v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.xconomy.com/boston/2009/01/27/innovative-spinal-technologies-jilted-now-bankrupt-source-says/","source_description":"Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says","raised_amount":18000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":9,"funded_day":8,"company":{"name":"Innovative Spinal Technologies","permalink":"innovative-spinal-technologies","image":null}}},{"funding_round":{"round_code":"d","source_url":"http://www.kalobios.com/kb_news_2008_12_22.php","source_description":"KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":12,"funded_day":22,"company":{"name":"KaloBios Pharmaceuticals","permalink":"kalobios-pharmaceuticals","image":{"available_sizes":[[[150,42],"assets/images/resized/0004/8539/48539v1-max-150x150.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-250x250.jpg"],[[161,46],"assets/images/resized/0004/8539/48539v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/elixir-pharmaceuticals-inc-series-d-12m/","source_description":"Elixir Pharmaceuticals, Inc.: Series D $12M","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":5,"funded_day":27,"company":{"name":"Elixir Pharmaceuticals","permalink":"elixir-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0004/9232/49232v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0004/9232/49232v1-max-250x250.jpg"],[[450,75],"assets/images/resized/0004/9232/49232v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2006/11/29/elixir-raises-46m-for-fountain-of-youth/","source_description":"Elixir raises $46M for fountain of youth","raised_amount":46000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":29,"company":{"name":"Elixir Pharmaceuticals","permalink":"elixir-pharmaceuticals","image":{"available_sizes":[[[150,25],"assets/images/resized/0004/9232/49232v1-max-150x150.jpg"],[[250,42],"assets/images/resized/0004/9232/49232v1-max-250x250.jpg"],[[450,75],"assets/images/resized/0004/9232/49232v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://onbiovc.com/xanodyne-pharmaceuticals-inc-series-d-38m/","source_description":"Xanodyne Pharmaceuticals, Inc.: Series D $38M","raised_amount":38000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":23,"company":{"name":"Xanodyne","permalink":"xanodyne","image":{"available_sizes":[[[150,49],"assets/images/resized/0005/0368/50368v1-max-150x150.png"],[[250,83],"assets/images/resized/0005/0368/50368v1-max-250x250.png"],[[286,95],"assets/images/resized/0005/0368/50368v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://investors.aryx.com/releasedetail.cfm?ReleaseID=347282","source_description":"ARYx Therapeutics Inc. Announces $21.6 Million Private Placement","raised_amount":21600000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":12,"company":{"name":"ARYx Therapeutics","permalink":"aryx-therapeutics","image":{"available_sizes":[[[150,61],"assets/images/resized/0005/2970/52970v1-max-150x150.jpg"],[[199,81],"assets/images/resized/0005/2970/52970v1-max-250x250.jpg"],[[199,81],"assets/images/resized/0005/2970/52970v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://deals.venturebeat.com/2006/12/08/neovista-a-co-targeting-age-related-macular-degeneration-raises-41m/","source_description":"NeoVista, a co. targeting age-related macular degeneration, raises $41M","raised_amount":41000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":12,"funded_day":8,"company":{"name":"NeoVista","permalink":"neovista","image":{"available_sizes":[[[150,102],"assets/images/resized/0005/9227/59227v1-max-150x150.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-250x250.jpg"],[[219,150],"assets/images/resized/0005/9227/59227v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://deals.venturebeat.com/2008/03/31/boston-scientific-spinout-trivascular2-takes-in-65m/","source_description":"Boston Scientific spinout TriVascular2 takes in $65M","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":31,"company":{"name":"TriVascular2","permalink":"trivascular2","image":{"available_sizes":[[[150,53],"assets/images/resized/0006/0715/60715v1-max-150x150.png"],[[250,88],"assets/images/resized/0006/0715/60715v1-max-250x250.png"],[[256,91],"assets/images/resized/0006/0715/60715v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.biocetera.com/inthenews.php?id=121265","source_description":"iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming","raised_amount":11500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":8,"company":{"name":"iPierian","permalink":"ipierian","image":{"available_sizes":[[[142,99],"assets/images/resized/0006/0988/60988v1-max-150x150.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-250x250.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://ir.pharmathene.com/phoenix.zhtml?c=191999&p=irol-newsArticle&ID=1312215&highlight=","source_description":"PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants","raised_amount":19300000,"raised_currency_code":"USD","funded_year":2009,"funded_month":7,"funded_day":27,"company":{"name":"PharmAthene","permalink":"pharmathene","image":{"available_sizes":[[[150,49],"assets/images/resized/0006/0993/60993v1-max-150x150.jpg"],[[223,73],"assets/images/resized/0006/0993/60993v1-max-250x250.jpg"],[[223,73],"assets/images/resized/0006/0993/60993v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/epizyme-pulls-32m-vc-capital-new-investors/2009-10-07?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0#ixzz0TIDqj9B1","source_description":"Epizyme pulls in $32M in VC capital, new investors","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":7,"company":{"name":"Epizyme","permalink":"epizyme","image":{"available_sizes":[[[150,74],"assets/images/resized/0006/1969/61969v1-max-150x150.jpg"],[[250,124],"assets/images/resized/0006/1969/61969v1-max-250x250.jpg"],[[450,224],"assets/images/resized/0006/1969/61969v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/primeradx-inc-series-c-20m/","source_description":"PrimeraDx, Inc.: Series C $20M","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":30,"company":{"name":"PrimeraDx","permalink":"primeradx","image":{"available_sizes":[[[150,40],"assets/images/resized/0006/4292/64292v3-max-150x150.png"],[[250,66],"assets/images/resized/0006/4292/64292v3-max-250x250.png"],[[450,120],"assets/images/resized/0006/4292/64292v3-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.fiercebiotech.com/story/oxagen-rounds-26-7m-vc/2009-11-24?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"Oxagen rounds up $26.7M in VC","raised_amount":26700000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":24,"company":{"name":"Oxagen","permalink":"oxagen","image":{"available_sizes":[[[150,45],"assets/images/resized/0006/7578/67578v1-max-150x150.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-250x250.png"],[[152,46],"assets/images/resized/0006/7578/67578v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.trivascular2.com/pdfdocs/Series_B_Press_Release_FINAL.pdf","source_description":"TriVascular","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2009,"funded_month":11,"funded_day":16,"company":{"name":"TriVascular","permalink":"trivascular","image":{"available_sizes":[[[150,53],"assets/images/resized/0006/7932/67932v1-max-150x150.png"],[[250,88],"assets/images/resized/0006/7932/67932v1-max-250x250.png"],[[256,91],"assets/images/resized/0006/7932/67932v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.devicespace.com/company_profile.aspx?CompanyId=620520","source_description":"DeviceSpace","raised_amount":65000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":3,"funded_day":31,"company":{"name":"TriVascular","permalink":"trivascular","image":{"available_sizes":[[[150,53],"assets/images/resized/0006/7932/67932v1-max-150x150.png"],[[250,88],"assets/images/resized/0006/7932/67932v1-max-250x250.png"],[[256,91],"assets/images/resized/0006/7932/67932v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.xconomy.com/seattle/2003/06/04/endogastric-solutions-garners-5000000-series-a-funding/","source_description":"Xconomy Seattle","raised_amount":5000000,"raised_currency_code":"USD","funded_year":2003,"funded_month":6,"funded_day":4,"company":{"name":"EndoGastric Solutions","permalink":"endogastric-solutions","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/7935/67935v1-max-150x150.png"],[[250,42],"assets/images/resized/0006/7935/67935v1-max-250x250.png"],[[311,53],"assets/images/resized/0006/7935/67935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.xconomy.com/seattle/2004/09/11/endogastric-solutions-secures-12000000-series-b-funding/","source_description":"Xconomy Seattle","raised_amount":12000000,"raised_currency_code":"USD","funded_year":2004,"funded_month":9,"funded_day":11,"company":{"name":"EndoGastric Solutions","permalink":"endogastric-solutions","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/7935/67935v1-max-150x150.png"],[[250,42],"assets/images/resized/0006/7935/67935v1-max-250x250.png"],[[311,53],"assets/images/resized/0006/7935/67935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2009/06/30/endogastric-solutions-obtains-3750000-new-funding/","source_description":"Xconomy Seattle","raised_amount":3750000,"raised_currency_code":"USD","funded_year":2009,"funded_month":6,"funded_day":30,"company":{"name":"EndoGastric Solutions","permalink":"endogastric-solutions","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/7935/67935v1-max-150x150.png"],[[250,42],"assets/images/resized/0006/7935/67935v1-max-250x250.png"],[[311,53],"assets/images/resized/0006/7935/67935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2009/10/12/endogastric-solutions-lands-9500000-new-financing-round/","source_description":"Xconomy Seattle","raised_amount":9500000,"raised_currency_code":"USD","funded_year":2009,"funded_month":10,"funded_day":12,"company":{"name":"EndoGastric Solutions","permalink":"endogastric-solutions","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/7935/67935v1-max-150x150.png"],[[250,42],"assets/images/resized/0006/7935/67935v1-max-250x250.png"],[[311,53],"assets/images/resized/0006/7935/67935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"e","source_url":"http://onbiovc.com/endogastric-solutions-inc-series-e-215m/","source_description":"EndoGastric Solutions, Inc.: Series E $21.5M","raised_amount":21500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":20,"company":{"name":"EndoGastric Solutions","permalink":"endogastric-solutions","image":{"available_sizes":[[[150,25],"assets/images/resized/0006/7935/67935v1-max-150x150.png"],[[250,42],"assets/images/resized/0006/7935/67935v1-max-250x250.png"],[[311,53],"assets/images/resized/0006/7935/67935v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/alnara-grabs-35m-vc-cash-it-aims-nda/2010-01-28?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","source_description":"http://www.fiercebiotech.com/story/alnara-grabs-35m-vc-cash-it-aims-nda/2010-01-28?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0","raised_amount":35000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":28,"company":{"name":"Alnara Pharmaceuticals","permalink":"alnara-pharmaceuticals","image":{"available_sizes":[[[150,35],"assets/images/resized/0005/0698/50698v1-max-150x150.png"],[[250,58],"assets/images/resized/0005/0698/50698v1-max-250x250.png"],[[260,61],"assets/images/resized/0005/0698/50698v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.radiuspharm.com/Radius2ndFinancing.pdf","source_description":"Radius Raises $57.5 Million in Second Private Financing Round","raised_amount":57500000,"raised_currency_code":"USD","funded_year":2007,"funded_month":4,"funded_day":2,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://altapartners.com/news_detail.php?id=215","source_description":"Ceregene Partners With Genzyme, Inks $28M Series C","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":6,"funded_day":22,"company":{"name":"Ceregene","permalink":"ceregene","image":{"available_sizes":[[[150,59],"assets/images/resized/0007/9928/79928v1-max-150x150.jpg"],[[250,98],"assets/images/resized/0007/9928/79928v1-max-250x250.jpg"],[[363,143],"assets/images/resized/0007/9928/79928v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.allbusiness.com/company-activities-management/board-management-changes/5299825-1.html","source_description":"Allozyne, Inc., Closes $30 Million Series B Financing","raised_amount":30000000,"raised_currency_code":"USD","funded_year":2007,"funded_month":10,"funded_day":26,"company":{"name":"Allozyne","permalink":"allozyne","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.fiercebiotech.com/story/rhythm-pharma-raises-21m-metabolic-diseases/2010-03-15?utm_medium=rss&utm_source=rss","source_description":"Rhythm Pharma raises $21M for metabolic diseases","raised_amount":21000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":15,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://onbiovc.com/syndax-pharmaceuticals-inc-series-a-9m/","source_description":"Syndax Pharmaceuticals, Inc.: Series A $9M","raised_amount":9000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":16,"company":{"name":"Syndax Pharmaceuticals","permalink":"sndax-pharmaceuticals","image":{"available_sizes":[[[150,60],"assets/images/resized/0008/0485/80485v1-max-150x150.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-250x250.png"],[[206,83],"assets/images/resized/0008/0485/80485v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.vlstcorp.com/files/pr/pr061606.pdf","source_description":"VLST Corporation Raises $55 Million","raised_amount":55000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":6,"funded_day":16,"company":{"name":"VLST Corporation","permalink":"vlst-corporation","image":{"available_sizes":[[[150,76],"assets/images/resized/0008/4234/84234v1-max-150x150.jpg"],[[189,96],"assets/images/resized/0008/4234/84234v1-max-250x250.jpg"],[[189,96],"assets/images/resized/0008/4234/84234v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://macrogenics.com/press_releases-244.html","source_description":"MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":5,"funded_day":17,"company":{"name":"MacroGenics","permalink":"macrogenics","image":{"available_sizes":[[[150,95],"assets/images/resized/0005/9708/59708v1-max-150x150.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-250x250.jpg"],[[188,120],"assets/images/resized/0005/9708/59708v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.allbusiness.com/technology/3930338-1.html","source_description":"Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology.","raised_amount":44000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":11,"funded_day":15,"company":{"name":"Chiasma","permalink":"chiasma","image":{"available_sizes":[[[150,43],"assets/images/resized/0008/4257/84257v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0008/4257/84257v1-max-250x250.jpg"],[[259,75],"assets/images/resized/0008/4257/84257v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.fiercebiotech.com/story/big-pharma-groups-back-43m-round-neurotherapeutics/2010-05-20?utm_medium=rss&utm_source=rss","source_description":"Big Pharma firms back $43M round for NeuroTherapeutics","raised_amount":43000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":5,"funded_day":20,"company":{"name":"NeuroTherapeutics Pharma","permalink":"neurotherapeutics-pharma","image":{"available_sizes":[[[150,45],"assets/images/resized/0008/8127/88127v1-max-150x150.jpg"],[[250,76],"assets/images/resized/0008/8127/88127v1-max-250x250.jpg"],[[318,97],"assets/images/resized/0008/8127/88127v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://cellerant.com/pdf/press_050511.pdf","source_description":"CELLERANT THERAPEUTICS RAISES $16 MILLION TO ADVANCE STEM CELL-BASED THERAPIES FOR LIFE-THREATENING DISEASES","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2005,"funded_month":5,"funded_day":11,"company":{"name":"Cellerant Therapeutics","permalink":"cellerant-therapeutics","image":{"available_sizes":[[[150,41],"assets/images/resized/0005/9578/59578v1-max-150x150.jpg"],[[172,48],"assets/images/resized/0005/9578/59578v1-max-250x250.jpg"],[[172,48],"assets/images/resized/0005/9578/59578v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/trivascular-inc-series-c-60m/","source_description":"TriVascular, Inc.: Series C $60M","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":8,"funded_day":12,"company":{"name":"TriVascular","permalink":"trivascular","image":{"available_sizes":[[[150,53],"assets/images/resized/0006/7932/67932v1-max-150x150.png"],[[250,88],"assets/images/resized/0006/7932/67932v1-max-250x250.png"],[[256,91],"assets/images/resized/0006/7932/67932v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.xconomy.com/seattle/2010/03/19/theraclone-raises-1-5m/","source_description":"Theraclone Raises $1.5M","raised_amount":1500000,"raised_currency_code":"USD","funded_year":2010,"funded_month":3,"funded_day":17,"company":{"name":"Theraclone Sciences","permalink":"theraclone-sciences","image":{"available_sizes":[[[150,32],"assets/images/resized/0009/4651/94651v1-max-150x150.jpg"],[[250,54],"assets/images/resized/0009/4651/94651v1-max-250x250.jpg"],[[305,67],"assets/images/resized/0009/4651/94651v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.goodwinprocter.com/News-and-Events/Press-Releases/2005/Allozyne-Inc-Raises-35-Million-in-Series-A-Funding.aspx","source_description":"Allozyne Inc. Raises $3.5 Million in Series A Funding","raised_amount":3500000,"raised_currency_code":"USD","funded_year":2005,"funded_month":12,"funded_day":6,"company":{"name":"Allozyne","permalink":"allozyne","image":{"available_sizes":[[[143,150],"assets/images/resized/0008/0052/80052v1-max-150x150.jpg"],[[239,250],"assets/images/resized/0008/0052/80052v1-max-250x250.jpg"],[[244,255],"assets/images/resized/0008/0052/80052v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"https://www.fis.dowjones.com/article.aspx?ProductIDFromApplication=29&aid=DJFVLS0020100908e6990008d&r=Rss&s=DJFVLS","source_description":"IPierian Announces Second Close Of Series B Financing At $28M  ","raised_amount":28000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":9,"funded_day":9,"company":{"name":"iPierian","permalink":"ipierian","image":{"available_sizes":[[[142,99],"assets/images/resized/0006/0988/60988v1-max-150x150.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-250x250.png"],[[142,99],"assets/images/resized/0006/0988/60988v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2010/11/verastem-closes-16m-series-financing.html","source_description":"Verastem Closes $16M Series A Financing","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":11,"funded_day":16,"company":{"name":"Verastem","permalink":"verastem","image":{"available_sizes":[[[150,48],"assets/images/resized/0011/0535/110535v1-max-150x150.jpg"],[[250,80],"assets/images/resized/0011/0535/110535v1-max-250x250.jpg"],[[450,145],"assets/images/resized/0011/0535/110535v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2011/01/aratana-therapeutics-closes-20-series.html","source_description":"Aratana Therapeutics Closes $20 Series A Financing","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":1,"funded_day":7,"company":{"name":"Aratana Therapeutics","permalink":"aratana-therapeutics","image":null}}},{"funding_round":{"round_code":"b","source_url":"http://money.msn.com/business-news/article.aspx?feed=PR&Date=20110412&ID=13301509&topic=TOPIC_FINANCING&isub=1","source_description":"Conatus Pharmaceuticals Completes the Second Closing of its Series B Private Placement Financing","raised_amount":7500000,"raised_currency_code":"USD","funded_year":2011,"funded_month":4,"funded_day":12,"company":{"name":"Conatus Pharmaceuticals","permalink":"conatus-pharmaceuticals","image":{"available_sizes":[[[150,39],"assets/images/resized/0012/1771/121771v1-max-150x150.jpg"],[[197,52],"assets/images/resized/0012/1771/121771v1-max-250x250.jpg"],[[197,52],"assets/images/resized/0012/1771/121771v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.masshightech.com/stories/2011/07/11/daily35-Verastem-rounds-up-32M-in-second-funding.html","source_description":"Verastem rounds up $32M in second funding","raised_amount":32000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":14,"company":{"name":"Verastem","permalink":"verastem","image":{"available_sizes":[[[150,48],"assets/images/resized/0011/0535/110535v1-max-150x150.jpg"],[[250,80],"assets/images/resized/0011/0535/110535v1-max-250x250.jpg"],[[450,145],"assets/images/resized/0011/0535/110535v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/07/nevro-completes-58m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Nevro Completes $58M Financing","raised_amount":58000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":19,"company":{"name":"Nevro","permalink":"nevro","image":{"available_sizes":[[[135,85],"assets/images/resized/0012/6898/126898v1-max-150x150.jpg"],[[135,85],"assets/images/resized/0012/6898/126898v1-max-250x250.jpg"],[[135,85],"assets/images/resized/0012/6898/126898v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-66m/","source_description":"Radius Health, Inc.: Series C $66M","raised_amount":66000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":7,"funded_day":26,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2011/09/valeritas-raises-150m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Valeritas Raises $150m in Series C financing.","raised_amount":150000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":9,"funded_day":12,"company":{"name":"Valeritas","permalink":"valeritas","image":{"available_sizes":[[[143,52],"assets/images/resized/0009/2151/92151v2-max-150x150.jpg"],[[143,52],"assets/images/resized/0009/2151/92151v2-max-250x250.jpg"],[[143,52],"assets/images/resized/0009/2151/92151v2-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.masshightech.com/stories/2011/11/07/daily38-Verastem-with-IPO-planned-raises-20M-in-funding.html","source_description":"Verastem, with IPO planned, raises $20M in funding","raised_amount":20000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":11,"funded_day":11,"company":{"name":"Verastem","permalink":"verastem","image":{"available_sizes":[[[150,48],"assets/images/resized/0011/0535/110535v1-max-150x150.jpg"],[[250,80],"assets/images/resized/0011/0535/110535v1-max-250x250.jpg"],[[450,145],"assets/images/resized/0011/0535/110535v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.finsmes.com/2011/12/aratana-therapeutics-closes-15m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Aratana Therapeutics Closes $15M Series B Financing","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":12,"funded_day":7,"company":{"name":"Aratana Therapeutics","permalink":"aratana-therapeutics","image":null}}},{"funding_round":{"round_code":"c","source_url":"http://radiuspharm.mwnewsroom.com/getattachment/6bc08185-9982-4ca1-8016-ab824b0ed0d7/Radius-Raises-Additional-$15-Million,-Increasing-S","source_description":"Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million","raised_amount":15000000,"raised_currency_code":"USD","funded_year":2008,"funded_month":11,"funded_day":20,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://onbiovc.com/radius-health-inc-series-c-214m/","source_description":"Radius Health, Inc.: Series C $21.4M","raised_amount":21400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":2,"funded_day":13,"company":{"name":"Radius Health","permalink":"radius-health","image":{"available_sizes":[[[150,73],"assets/images/resized/0007/9893/79893v1-max-150x150.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-250x250.jpg"],[[163,80],"assets/images/resized/0007/9893/79893v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"unattributed","source_url":"http://www.finsmes.com/2012/05/celladon-raises-additional-10m.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Celladon Raises Additional $10M","raised_amount":10000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":5,"funded_day":8,"company":{"name":"Celladon","permalink":"celladon","image":{"available_sizes":[[[150,19],"assets/images/resized/0006/4625/64625v1-max-150x150.jpg"],[[250,33],"assets/images/resized/0006/4625/64625v1-max-250x250.jpg"],[[338,45],"assets/images/resized/0006/4625/64625v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://news.yahoo.com/trivascular-secures-60-million-equity-financing-071937638.html","source_description":"TriVascular Secures $60 Million in Equity Financing","raised_amount":60000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":4,"company":{"name":"TriVascular","permalink":"trivascular","image":{"available_sizes":[[[150,53],"assets/images/resized/0006/7932/67932v1-max-150x150.png"],[[250,88],"assets/images/resized/0006/7932/67932v1-max-250x250.png"],[[256,91],"assets/images/resized/0006/7932/67932v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"c","source_url":"http://www.finsmes.com/2012/06/astute-medical-completes-40-4m-series-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Astute Medical Completes $40.4M Series C Financing","raised_amount":40400000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":7,"company":{"name":"Astute Medical","permalink":"astute-medical","image":{"available_sizes":[[[150,56],"assets/images/resized/0004/7322/47322v2-max-150x150.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-250x250.png"],[[169,64],"assets/images/resized/0004/7322/47322v2-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.rhythmtx.com/NEWS/releases/061312.html","source_description":"Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":6,"funded_day":13,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"d","source_url":"http://www.finsmes.com/2012/07/chiasma-closes-38-5m-series-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Chiasma Closes $38.5M Series D Equity Financing","raised_amount":38500000,"raised_currency_code":"USD","funded_year":2012,"funded_month":7,"funded_day":23,"company":{"name":"Chiasma","permalink":"chiasma","image":{"available_sizes":[[[150,43],"assets/images/resized/0008/4257/84257v1-max-150x150.jpg"],[[250,72],"assets/images/resized/0008/4257/84257v1-max-250x250.jpg"],[[259,75],"assets/images/resized/0008/4257/84257v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://www.finsmes.com/2012/09/vascular-pharmaceuticals-completes-16m-series-equity-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Vascular Pharmaceuticals Completes $16M Series A Equity Financing","raised_amount":16000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":12,"company":{"name":"Vascular Pharmaceuticals","permalink":"vascular-pharmaceuticals","image":{"available_sizes":[[[44,30],"assets/images/resized/0021/1105/211105v1-max-150x150.png"],[[44,30],"assets/images/resized/0021/1105/211105v1-max-250x250.png"],[[44,30],"assets/images/resized/0021/1105/211105v1-max-450x450.png"]],"attribution":null}}}},{"funding_round":{"round_code":"a","source_url":"http://finance.yahoo.com/news/selexys-pharmaceuticals-completes-23m-equity-130000708.html","source_description":"Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company","raised_amount":23000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":9,"funded_day":20,"company":{"name":"Selexys Pharmaceuticals Corporation","permalink":"selexys-pharmaceuticals-corporation","image":{"available_sizes":[[[150,44],"assets/images/resized/0021/2146/212146v1-max-150x150.jpg"],[[184,55],"assets/images/resized/0021/2146/212146v1-max-250x250.jpg"],[[184,55],"assets/images/resized/0021/2146/212146v1-max-450x450.jpg"]],"attribution":null}}}},{"funding_round":{"round_code":"b","source_url":"http://www.pehub.com/174484/rhythm-adds-8m-cap-series-b-33m/","source_description":"Rhythm Adds $8M to Cap Series B at $33M","raised_amount":8000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":11,"funded_day":27,"company":{"name":"Rhythm Pharmaceuticals","permalink":"rhythm-pharmaceuticals","image":{"available_sizes":[[[150,70],"assets/images/resized/0008/0469/80469v10-max-150x150.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-250x250.jpg"],[[168,79],"assets/images/resized/0008/0469/80469v10-max-450x450.jpg"]],"attribution":null}}}}],"milestones":[],"providerships":[],"funds":[{"name":"$550M HealthCare Fund","funded_year":2007,"funded_month":3,"funded_day":5,"raised_amount":550000000,"raised_currency_code":"USD","source_url":"http://venturebeat.com/2007/03/05/mpm-capital-raises-550m-healthcare-fund/","source_description":"MPM Capital raises $550M healthcare fund"},{"name":"MPM BioVentures V","funded_year":2010,"funded_month":2,"funded_day":15,"raised_amount":140000000,"raised_currency_code":"USD","source_url":"http://www.masshightech.com/stories/2010/02/15/daily3-MPM-BioVentures-ups-fund-to-140M.html","source_description":"MPM BioVentures ups fund to $140M"}],"video_embeds":[],"external_links":[]}